Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study.
By F. Wackers, L. Young, Silvio E. Inzucchi, D. Chyun, Janice A. Davey, E. Barrett, R. Taillefer, S. Wittlin, G. Heller, N. Filipchuk and 3 more. Diabetes Care, 2004
862 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/9b0cbb067a5c525931d965cb0bc23732bdcf5063
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Pathology and Forensic Medicine
In Radiology, Nuclear Medicine and Imaging
Citations in the corpus
- Standards of Medical Care in Diabetes—2014 (2013, background): “Despite the intuitive appeal, recent studies have found that a risk factor– based approach to the initial diagnostic evaluation and subsequent follow-up for CAD fails to identify which patients with type 2 diabetes will have silent ischemia on screening tests (398,399).”
- Diabetic Cardiovascular Autonomic Neuropathy (2007, background): “In the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study of 1123 patients with type 2 diabetes, cardiac autonomic dysfunction was a strong predictor of ischemia.(34) Thus, patients with CAN warrant more careful attention, and cardiovascular autonomic function testing may be an important c”
- Standards of Medical Care in Diabetes–2006 (2006, background): “Autonomic neuropathy is also strongly associated with CVD in people with diabetes (76,77).”
- Standards of Medical Care in Diabetes—2009 (2009, background): “Autonomic neuropathy is also strongly associated with CVD in people with diabetes (130,131).”
- Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management (2011, methodology): “At baseline, the Detection of Ischaemia in Asymptomatic Diabetics (DIAD) study showed that in 1123 type 2 diabetic patients the lowest quartile of the Valsalva ratio was the strongest determinant of SMI, which was defined as abnormal stress adenosine Tc-99m sestamibi Single Photon Emission Computed ”
- Standards of Medical Care in Diabetes—2013 (2012, background): “However, recent studies concluded that using this approach fails to identify which patients with type 2 diabetes will have silent ischemia on screening tests (201,321).”
- Standards of Medical Care in Diabetes—2012 (2011, background): “A recent study concluded that using current guidelines fails to detect a significant percentage of patients with silent ischemia (99).”
- Standards of Medical Care in Diabetes—2020 Abridged for Primary Care Providers (2019, background): “) of regular exercise for those with type 1 diabetes (152).”
- Standards of Medical Care in Diabetes—2008 (2008, background): “Autonomic neuropathy is also strongly associated with CVD in people with diabetes (100,101).”